Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Enable Injections Enters into Partnership with Sanofi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Enable Injections Enters into Partnership with Sanofi

Enable's enFuse delivers high-volume therapeutics outside of the clinical setting

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enable Injections, a company developing and manufacturing advanced wearable infusion devices for combination products, has entered into a multi-product development agreement with Sanofi. The enFuse, developed and manufactured by Enable Injections, enables patient-administered subcutaneous delivery of high-volume therapeutics outside of a healthcare facility.
 
The Enable-Sanofi partnership includes multiple molecule development programs incorporating long-term manufacturing and supply arrangements.
 
The Enable enFuse is an on-body drug delivery platform with a self-contained drug transfer system compatible with standard syringes or vial container formats. The wearable enFuse platform is being developed for controlled subcutaneous administration of large-volumes ranging from 5 mL to 50 mL. Designed for ease of use, the enFuse has the potential to provide patients and their caregivers an alternative delivery method for subcutaneous administration of parenteral therapies outside of a clinical setting.
 
“Enable is delighted to partner with Sanofi in its mission to deliver patient-focused solutions,” said Michael Hooven, president and chief executive officer, Enable Injections. “Enable Injections has engineered the enFuse with the patient experience in mind, with the aim of increasing adherence and achieving the outcomes necessary for our partners’ commercial success.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics